Trevena, Inc is an innovative biopharmaceutical company based in Chesterbrook, PA, dedicated to developing groundbreaking medicines for patients with central nervous system (CNS) disorders. Their pipeline includes one FDA-approved product, OLINVYK oliceridine injection, and three differentiated investigational drug candidates, targeting various therapeutic areas such as acute pain, diabetic neuropathic pain, epilepsy, acute migraine, and opioid use disorder.
With a focus on targeted and innovative CNS therapies, Trevena's pipeline is built on Nobel Prize-winning research and aims to address the critical needs of patients. Their commitment to innovation and patient care drives their mission to deliver effective treatments for CNS disorders.
Generated from the website